Medication info
Twintela Tablet 40/5 mg

Twintela Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
White and light blue biconvex oval double-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201901232 · Approved 2019.02.26 · Insurance code 670501380

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan or amlodipine monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of the individual component (telmisartan or amlodipine) be adjusted. However, if blood pressure is not controlled with an individual component, switching directly to this medicine may be considered as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 milligrams. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section 3, “Patients Requiring Caution”). In patients aged 75 years or older, clearance of amlodipine is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
This medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan or amlodipine monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension for whom adequate blood pressure control is difficult with either telmisartan or amlodipine monotherapy.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of the individual component (telmisartan or amlodipine) be adjusted. However, if blood pressure is not controlled with an individual component, switching directly to this medicine may be considered as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 milligrams. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section 3, “Patients Requiring Caution”). In patients aged 75 years or older, clearance of amlodipine is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

This medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should not be used during pregnancy. This medication should not be used in individuals with an allergy to the active ingredients or similar compounds, pregnant or potentially pregnant women, nursing mothers, individuals with severe liver disease or specific cardiac diseases, and patients with severe hypotension. Patients with impaired liver or kidney function, those with certain heart valve diseases, gastrointestinal diseases, renal artery hypertension, patients on dialysis, and elderly patients should use this medication with caution. Common side effects that may occur while taking this medication include dizziness and swelling of the ankles or legs, and severe side effects can also occur, so if any abnormal symptoms appear, you should notify the physician immediately. This medication should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and substituted with another safe treatment. This medication lowers blood pressure, which may lead to hypotension; if hypotensive symptoms arise, lying down or, if necessary, fluid therapy may be required. There is a risk of increasing potassium levels in the blood, so care should be taken when using potassium supplements or consuming foods high in potassium, and regular blood tests are recommended. Patients with impaired kidney function should periodically test their kidney function and electrolyte levels while taking this medication. This medication may interact with other drugs; if you are taking any other medications, it’s crucial to inform your doctor or pharmacist, especially when taken with specific heart medications, diuretics, anti-inflammatory pain relievers, and lithium. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating machinery. In cases of overdose, severe hypotension or cardiac issues may occur, so avoid exceeding the prescribed dosage and visit a medical facility immediately if an overdose is suspected. This medication is not recommended for children as its safety and efficacy have not been established, and elderly patients should take it carefully with dosage adjustments.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • reduced sensation
  • taste disturbances
  • tremors
  • extrapyramidal disorders
  • increased muscle tone
  • visual impairments
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal gas retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • arthralgia
  • muscle cramps
  • joint pain
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is not exposed to light, at a temperature between 1 to 30 degrees Celsius. Storing it this way helps to maintain the medication's effectiveness.

Appearance and packaging

Appearance

White and light blue biconvex oval double-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.